Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar kylehusky (< 20) Submitted: 7/1/2011 3:38:20 AM : Outperform Start Price: $3.20 SVA Score: -44.70

pharm. stock is always risky, but when disease pops out this is the best pharm. stock you can bet in China.

Featured Broker Partners


Advertisement